BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24045507)

  • 1. Immunological evaluation of a novel Mycobacterium tuberculosis antigen, Rv3117, absent in Mycobacterium bovis BCG.
    Zhao J; Sun Z; Pei H; Ye J; Chen C; Samten B; Zhang S; Guo X
    Mol Med Rep; 2013 Nov; 8(5):1587-93. PubMed ID: 24045507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Mycobacterium tuberculosis-specific recombinant antigens and evaluation of the clinical value of antibody detection for serological diagnosis of pulmonary tuberculosis.
    Zhang X; Su Z; Zhang X; Hu C; Yu J; Gao Q; Wang H
    Int J Mol Med; 2013 Mar; 31(3):751-7. PubMed ID: 23338746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
    Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
    J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel recombinant BCG coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular immune and antibody responses in C57BL/6 mice.
    Lu Y; Xu Y; Yang E; Wang C; Wang H; Shen H
    Scand J Immunol; 2012 Sep; 76(3):271-7. PubMed ID: 22671973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
    Deng YH; Sun Z; Yang XL; Bao L
    Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
    Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
    Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune effects research of interleukin 12 and Mycobacterium tuberculosis ESAT-6 antigen combined DNA immunization].
    Hao M; Bao L; Gao L
    Wei Sheng Wu Xue Bao; 2007 Jun; 47(3):477-81. PubMed ID: 17672309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB/c mice.
    Christy AJ; Dharman K; Dhandapaani G; Palaniyandi K; Gupta UD; Gupta P; Ignacimuthu S; Narayanan S
    Vaccine; 2012 Feb; 30(7):1364-70. PubMed ID: 22200502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical and immunological characterization of the ESX-4 system ESAT-6 family proteins Rv3444c and Rv3445c from Mycobacterium tuberculosis H37Rv.
    Pandey H; Fatma F; Yabaji SM; Kumari M; Tripathi S; Srivastava K; Tripathi DK; Kant S; Srivastava KK; Arora A
    Tuberculosis (Edinb); 2018 Mar; 109():85-96. PubMed ID: 29559126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
    Xu J; Xu W; Chen X; Zhao D; Wang Y
    Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals.
    Martinez V; Carcelain G; Badell E; Jouan M; Mauger I; Sellier P; Truffot C; Bricaire F; Arend SM; Ottenhoff T; Autran B; Gicquel B
    BMC Infect Dis; 2007 Jul; 7():83. PubMed ID: 17655752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA response to ESAT-6/CFP-10 and Rv2031 antigens varies in patients with culture-confirmed pulmonary tuberculosis, healthy Mycobacterium tuberculosis-infected and non-infected individuals in a tuberculosis endemic setting, Ethiopia.
    Legesse M; Ameni G; Medhin G; Mamo G; Franken KL; Ottenhoff TH; Bjune G; Abebe F
    Scand J Immunol; 2013 Sep; 78(3):266-74. PubMed ID: 23713613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis.
    Al-Attiyah R; Mustafa AS; Abal AT; El-Shamy AS; Dalemans W; Skeiky YA
    Clin Exp Immunol; 2004 Oct; 138(1):139-44. PubMed ID: 15373916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis.
    Kebriaei A; Derakhshan M; Meshkat Z; Eidgahi MR; Rezaee SA; Farsiani H; Mosavat A; Soleimanpour S; Ghazvini K
    Mol Biol Rep; 2016 Sep; 43(9):911-22. PubMed ID: 27251218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.